Entera Bio Ltd.

NASDAQ:ENTX

Biotechnology

Healthcare
$3.28 +0.00%

+$0.00 today

Market cap
$571.17M
Beta
1.49
P/E (TTM)
-4.6
EPS (TTM)
-$0.26
52W Low $0.91High $3.22

Volume 0.23M

Average 0.16M

Income Statement

Follow revenue through to earnings.

Revenue

$42,000.00

FY 2025 · Annual

-76.8% YoY

Operating Income

-$11.53M

FY 2025 · Annual

Net Income

-$11.44M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue571K134K0181K42K
Cost of Revenue373K165K56K172K42K
Gross Profit198K(31K)(56K)9K0
Gross Margin34.7%-23.1%—5.0%0.0%
Research & Development6.77M5.78M4.45M4.5M6M
Selling, General & Admin5.69M7.25M4.43M5.1M5.53M
Operating Expenses12.42M13.04M8.88M9.59M11.53M
Depreciation & Amortization53K64K56K46K30K
EBITDA(12.16M)(12.87M)(8.8M)(9.48M)(11.41M)
EBITDA Margin-2130.3%-9604.5%—-5238.1%-27164.3%
Operating Income(12.22M)(13.07M)(8.94M)(9.59M)(11.53M)
Operating Margin-2139.6%-9752.2%—-5295.6%-27450.0%
Interest Income083K31K58K0
Interest Expense29K0000
Other Income / Expenses(29K)134K80K58K90K
Income Before Tax(12.25M)(12.93M)(8.86M)(9.53M)(11.44M)
Pre-Tax Margin-2144.7%-9652.2%—-5263.5%-27235.7%
Income Tax Expense(59K)137K29K14K0
Net Income(12.19M)(13.07M)(8.89M)(9.54M)(11.44M)
Net Margin-2134.3%-9754.5%—-5271.3%-27235.7%
EPS (Basic)(0.47)(0.45)(0.31)(0.25)(0.25)
EPS (Diluted)(0.47)(0.45)(0.31)(0.25)(0.25)
Weighted Avg Shares26.13M28.81M29.01M37.65M46.19M
Weighted Avg Shares (Diluted)26.13M28.81M29.01M37.65M46.19M

ENTX Earnings Waterfall · TTM

NASDAQ:ENTX · Revenue to Net Income

Key Ratios

EPS$-0.26
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-6.7
P/S Ratio0.0

Analysis

$0 of revenue converted into -$12.4M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.26, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 6, 2026
8-KCurrent reportNov 6, 2026
SC 13GSC 13G filingOct 30, 2026
8-KCurrent reportOct 27, 2026

How much revenue does ENTX generate?

Entera Bio Ltd. (ENTX) reported $42,000.00 of revenue in fiscal 2025.

Is ENTX profitable?

Entera Bio Ltd. (ENTX) reported -$11.44M of net income, with a net margin of -27235.7%.